{"SPADE_UN_18947": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_18947", "Peptide Name": "CD4-PP (cyclic dimeric KR-12 analog, synthetic AMPs, UCBB1)", "Source": "designed, human cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "CPGGKRIVKRIKAFLRGPGGKRIVKRIKAFLR", "Sequence Length": 32, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3620.5, "PI": 12.0, "Hydrophobicity": -0.31, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "White JK, Muhammad T, Alsheim E, Mohanty S, Blasi-Romero A, Gunasekera S, Strömstedt AA, Ferraz N, Göransson U, Brauner A. 2022", "Reference": "Cell Mol Life Sci. 2022 Jul 11;79(8):411. doi: 10.1007/s00018-022-04440-w.PubMed", "Title": "A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens."}], "Frequent Amino Acids": "KRG", "Absent Amino Acids": "DEHMNOQSTUWY", "Basic Residues": 12, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 17, "Positive Residues": 12, "Negative Residues": 0, "Net Charge": 12, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (81.82%) tocd4(Q5K,D9K)K=R: 19%, G: 16%, I: 13%. Designed by changing Q22 to K and D26 to A in KR-12 followed by connecting two copies of KR-12 with CPGG and GPGG.Activity: active against E. coli (MIC 0.312 uM) and P. aeruginosa (MIC 0.625 uM) in 10 mM tris buffer. Warning: other bacteria not tested.Structure: random coil in water and helical in lysoPG (78%).Peptide stability: CD4-PP gained stability to S. aureus protease aureolysin  (~20% detected after 6 h), while the control LL-37 was nearly completely degraded in 1 h.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22163", "Similarity": 1.0, "Sequence": "KRIVKRIKAFLR"}, {"SPADE_ID": "SPADE_UN_26527", "Similarity": 1.0, "Sequence": "KRIVRIKFLR"}, {"SPADE_ID": "SPADE_UN_17432", "Similarity": 0.9166666666666666, "Sequence": "KRIVARIKAFLR"}]}}}